Trial · NCT00359281
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Area Under Concentration-time Curve From 0 to Last Measureable Concentration (AUC0-t) Atorvastatin Acid (Lomitapide 10 mg) | 0 to 24 hour | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for atorvastatin acid (Lomitapide 10 mg) |
| Primary | AUC0-t Simvastatin | 0 to 24 hours | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for simvastatin |
| Primary | AUC0-t Simvastatin Acid | 0 to 24 hours | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for simvastatin acid |
| Primary | AUC0-t Total Ezetimibe | 0 to 24 hours | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for total ezetimibe |
| Primary | AUC0-t Rosuvastatin (Lomitapide 10 mg) | 0 to 24 hours | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for rosuvastatin (Lomitapide 10 mg) |
| Primary | AUC0-t Fenofibric Acid | 0 to 24 hours | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for fenofibric acid |
| Primary | AUC0-t Atorvastatin Acid (Lomitapide 60 mg) | 0 to 24 hours | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for atorvastatin acid (Lomitapide 60 mg) |
| Primary | AUC0-t Rosuvastatin (Lomitapide 60 mg) | 0 to 24 hours | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for rosuvastatin (Lomitapide 60 mg) |
| Primary | AUC0-t Nicotinic Acid | 0 to 24 hours | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for nicotinic acid |
| Primary | AUC0-t Nicotinuric Acid | 0 to 24 hours | Geometric Mean Ratio ln(AUC0-t) Day 8/Day 1 for nicotinuric acid |
| Secondary | Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) | Baseline to Day 8 | Percent change from Baseline in LDL-C |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00359281/registered